A phase I trial of adenovector-mediated delivery of interleukin-2 (AdIL-2) in high-risk localized prostate cancer (Q64377412)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14502228%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

title

A phase I trial of adenovector-mediated delivery of interleukin-2 (AdIL-2) in high-risk localized prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14502228%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

main subject

phase I clinical trial

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14502228%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

2

John Trachtenberg

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14502228%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

author name string

Suzane Trudel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14502228%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Ants Toi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14502228%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Zhi Hua Li

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14502228%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Michael Jewett

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14502228%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

John Tshilias

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14502228%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Li Hue Zhuang

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14502228%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Mary Hitt

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14502228%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Yonghong Wan

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14502228%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Jack Gauldie

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14502228%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Frank L Graham

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14502228%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Janet Dancey

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14502228%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

A Keith Stewart

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14502228%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

language of work or name

English

0 references

publication date

1 October 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14502228%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14502228%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14502228%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14502228%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

page(s)

755-763

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14502228%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

cites work

Cancer statistics, 1999.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700626

7 January 2021

Patterns of Care and RTOG studies in prostate cancer: long-term survival, hazard rate observations, and possibilities of cure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700626

7 January 2021

Cancer Control and Quality of Life Following Anatomical Radical Retropubic Prostatectomy: Results at 10 Years

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700626

7 January 2021

Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700626

7 January 2021

A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700626

7 January 2021

Loss of HLA class I expression in prostate cancer: implications for immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700626

7 January 2021

Intratumoral depot interleukin-2 therapy inhibits tumor growth in Dunning adenocarcinoma of the prostate implanted subcutaneously in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700626

7 January 2021

Adenovector-mediated gene delivery of interleukin-2 in metastatic breast cancer and melanoma: results of a phase 1 clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700626

7 January 2021

Prospects of immunotherapy for the treatment of prostate carcinoma--a review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700626

7 January 2021

Pre-existing immunity to adenovirus does not prevent tumor regression following intratumoral administration of a vector expressing IL-12 but inhibits virus dissemination

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700626

7 January 2021

Toxicity associated with repeated administration of first-generation adenovirus vectors does not occur with a helper-dependent vector.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700626

7 January 2021

Interleukin 2 gene therapy for prostate cancer: phase I clinical trial and basic biology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700626

7 January 2021

Apples and oranges: building a consensus for standardized eligibility criteria and end points in prostate cancer clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700626

7 January 2021

Interleukin 12 and B7-1 costimulatory molecule expressed by an adenovirus vector act synergistically to facilitate tumor regression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700626

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7700626

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14502228%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

1 reference